Published in Nat Rev Nephrol on February 23, 2010
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. J Am Soc Nephrol (2012) 1.57
Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol (2011) 1.38
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest (2014) 1.24
A missense mutation in PKD1 attenuates the severity of renal disease. Kidney Int (2011) 1.19
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One (2013) 1.12
Determinants of renal disease variability in ADPKD. Adv Chronic Kidney Dis (2010) 1.11
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol (2016) 1.02
Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol (2010) 0.99
Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing. Mol Genet Genomic Med (2014) 0.95
Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol (2016) 0.94
Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways. Am J Physiol Renal Physiol (2012) 0.93
Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol (2015) 0.90
Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing. J Mol Diagn (2013) 0.90
DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome. Pediatr Nephrol (2013) 0.89
Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol (2014) 0.85
New treatments for autosomal dominant polycystic kidney disease. Br J Clin Pharmacol (2013) 0.85
How simple are 'simple renal cysts'? Nephrol Dial Transplant (2014) 0.85
The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD). Curr Hypertens Rev (2013) 0.84
Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases. Am J Physiol Renal Physiol (2015) 0.83
Living donor kidney transplantation in patients with hereditary nephropathies. Nat Rev Nephrol (2010) 0.82
Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease. BMC Med Genet (2014) 0.82
Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease. BMC Med Genet (2014) 0.81
ADPKD: Prototype of Cardiorenal Syndrome Type 4. Int J Nephrol (2010) 0.81
ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in Mice. PLoS One (2015) 0.78
Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014). Popul Health Metr (2017) 0.78
Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells. J Membr Biol (2015) 0.77
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents. Pediatr Nephrol (2016) 0.76
Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics. BMC Nephrol (2013) 0.76
System analysis of gene mutations and clinical phenotype in Chinese patients with autosomal-dominant polycystic kidney disease. Sci Rep (2016) 0.75
Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus. Can J Kidney Health Dis (2017) 0.75
Functional alterations due to amino acid changes and evolutionary comparative analysis of ARPKD and ADPKD genes. Genom Data (2016) 0.75
Progress in ciliary ion channel physiology. J Gen Physiol (2016) 0.75
Pathways, perspectives and pursuits in polycystic kidney disease. J Nephropharmacol (2015) 0.75
Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression. J Transl Med (2015) 0.75
Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet (2008) 68.81
Next-generation DNA sequencing. Nat Biotechnol (2008) 34.95
Real-time DNA sequencing from single polymerase molecules. Science (2008) 29.53
The impact of next-generation sequencing technology on genetics. Trends Genet (2008) 21.07
Amino acid difference formula to help explain protein evolution. Science (1974) 15.19
The potential and challenges of nanopore sequencing. Nat Biotechnol (2008) 14.24
Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet (2003) 13.33
Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res (2009) 10.08
Autosomal dominant polycystic kidney disease. Lancet (2007) 8.55
When cilia go bad: cilia defects and ciliopathies. Nat Rev Mol Cell Biol (2007) 8.28
Volume progression in polycystic kidney disease. N Engl J Med (2006) 7.16
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol (2002) 5.58
The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet (1995) 4.99
Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol (2002) 4.37
Next-generation sequencing: from basic research to diagnostics. Clin Chem (2009) 4.18
Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol (2008) 4.07
Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet (1994) 3.73
Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int (2009) 3.66
Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr Biol (2002) 3.55
Polycystin-1 and -2 dosage regulates pressure sensing. Cell (2009) 3.36
Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium. Cell (1995) 3.34
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet (1999) 3.32
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2007) 3.26
Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet (2009) 3.01
Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int (2009) 2.99
Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl (1957) 2.86
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet (2004) 2.47
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) (2006) 2.34
Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Natl Acad Sci U S A (2002) 2.29
Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet (2005) 2.24
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis (1983) 2.22
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2006) 2.21
Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet (1997) 2.06
Modifier genes play a significant role in the phenotypic expression of PKD1. Kidney Int (2005) 2.03
Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics (1999) 1.99
Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet (2004) 1.96
Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat Cell Biol (2005) 1.88
Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics (1995) 1.86
The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol (2003) 1.86
Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet (2000) 1.78
Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet (2003) 1.77
Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome. Kidney Int (2005) 1.72
Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history. Am J Kidney Dis (2008) 1.71
Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol (2003) 1.70
A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int (2002) 1.66
The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol (2002) 1.60
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int (2008) 1.58
Autosomal dominant polycystic kidney disease--more than a renal disease. Am J Kidney Dis (1990) 1.53
Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet (2009) 1.53
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2003) 1.48
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet (2003) 1.47
Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1. Am J Pathol (2006) 1.47
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet (2003) 1.47
Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet (1997) 1.45
The sequence and analysis of duplication-rich human chromosome 16. Nature (2004) 1.38
The remarkable mechanical strength of polycystin-1 supports a direct role in mechanotransduction. J Mol Biol (2005) 1.34
An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases. Am J Kidney Dis (1993) 1.32
Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2005) 1.32
Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab (2007) 1.31
Evidence of linkage disequilibrium in the Spanish polycystic kidney disease I population. Am J Hum Genet (1994) 1.28
Family history of renal disease severity predicts the mutated gene in ADPKD. J Am Soc Nephrol (2009) 1.23
Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum Mol Genet (2008) 1.20
Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Hum Mutat (2009) 1.20
The nanomechanics of polycystin-1 extracellular region. J Biol Chem (2005) 1.18
Rapid MR imaging detection of renal cysts: age-based standards. Radiology (2001) 1.15
Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clin J Am Soc Nephrol (2006) 1.15
Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family. Hum Genet (1995) 1.15
Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie. J Med Genet (1993) 1.13
Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2002) 1.12
Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol (2001) 1.12
Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin. J Biol Chem (2008) 1.10
Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation. Am J Transplant (2007) 1.09
A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet (1997) 1.04
Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome. Hum Genet (2002) 1.03
Variation in age at ESRD in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2008) 1.02
Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet (2003) 0.98
DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation (2009) 0.96
Naturally occurring mutations alter the stability of polycystin-1 polycystic kidney disease (PKD) domains. J Biol Chem (2009) 0.93
Massively enlarged polycystic kidneys in monozygotic twins with TCF2/HNF-1beta (hepatocyte nuclear factor-1beta) heterozygous whole-gene deletion. Am J Kidney Dis (2007) 0.90
Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations. Clin J Am Soc Nephrol (2007) 0.90
Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. Am J Kidney Dis (2001) 0.89
Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis (2000) 0.88
Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)? Nephrol Dial Transplant (1995) 0.87
PGD for autosomal dominant polycystic kidney disease type 1. Mol Hum Reprod (2004) 0.86
The diversity of PKD1 alleles: implications for disease pathogenesis and genetic counseling. Kidney Int (2009) 0.83
Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation (2009) 0.82
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet (2002) 4.54
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol (2010) 3.47
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) (2006) 2.34
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2006) 2.21
Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. J Am Soc Nephrol (2006) 1.95
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol (2011) 1.79
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J Clin Invest (2012) 1.74
Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am J Physiol Renal Physiol (2006) 1.72
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int (2008) 1.58
Sharing data between LSDBs and central repositories. Hum Mutat (2009) 1.57
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. Am J Kidney Dis (2003) 1.51
Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int (2005) 1.48
B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis. Hum Mol Genet (2011) 1.45
PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Hum Mutat (2004) 1.40
Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Am Soc Nephrol (2007) 1.39
Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells. Am J Physiol Renal Physiol (2009) 1.28
TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis. Nephrol Dial Transplant (2009) 1.21
Determinants of renal disease variability in ADPKD. Adv Chronic Kidney Dis (2010) 1.11
Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 1.04
Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis. J Nephrol (2006) 1.03
Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease. Am J Kidney Dis (2005) 1.01
Analysis of published PKD1 gene sequence variants. Nat Genet (2007) 0.98
Molecular genetics of autosomal recessive polycystic kidney disease. Mol Genet Metab (2004) 0.97
Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. J Mol Cell Cardiol (2013) 0.95
PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression. Hum Mol Genet (2003) 0.92
Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US. J Med Econ (2015) 0.84
A novel application of pattern recognition for accurate SNP and indel discovery from high-throughput data: targeted resequencing of the glucocorticoid receptor co-chaperone FKBP5 in a Caucasian population. Mol Genet Metab (2011) 0.83
Germline PKHD1 mutations are protective against colorectal cancer. Hum Genet (2011) 0.82
A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1. PLoS One (2013) 0.82
Investigation of primary cilia in the pathogenesis of biliary atresia. J Pediatr Gastroenterol Nutr (2011) 0.82
Molecular diagnostics of ADPKD coming of age. Clin J Am Soc Nephrol (2008) 0.79
Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics. BMC Nephrol (2013) 0.76
Mitochondrial causes of renal insufficiency and hearing loss. Kidney Int (2004) 0.75
Integrated strategies for allogeneic blood saving in major elective surgery. Transfus Apher Sci (2011) 0.75